Checking urine to help diagnose and predict risk of prostate cancer

Prostate cancer, after skin cancer, is the most common cancer for men.  Doctors check a specific prostate blood test- called PSA—to help them decide if a man may have prostate cancer.  Generally, if this test is abnormal, doctors may recommend a biopsy of the prostate to verify if there are cancer cells or not.  The PSA, however, is not always recommended as it is not 100% accurate and biopsies can be risky. 

Now, researchers have found a special urine test that can help. This new test, Mi Prostate Score-- called MiPS—checks 3 different markers that can help decide if there are cancer cells. This test alone is more accurate than PSA, but together the two tests predict cancer even better.

Researchers have found that two genes change places and is a cause of prostate cancer.  Even more exciting is that this new test can help identify more serious types of prostate cancers.  So, now when a man has high levels of PSA, the MiPS test can be done and if that is abnormal, doctors will have better information to decide if an immediate biopsy is worth doing or if it is safe to wait.

References (Click to View): 

European Urology, 2015

OncoTherapy, 2015